Carcino Embryonic Antigen (CEA), Serum
Product Overview
The Carcino Embryonic Antigen (CEA), Serum Test is a specialized blood test used primarily as a tumor marker to monitor certain types of cancers and evaluate treatment response. It measures the level of CEA, a protein that may be elevated in individuals with specific malignancies.
Why This Test is Important
CEA is commonly associated with:
-
Colorectal cancer
-
Lung cancer
-
Breast cancer
-
Pancreatic cancer
-
Gastric (stomach) cancer
This test is not typically used for screening but plays a crucial role in:
-
Monitoring cancer progression
-
Evaluating effectiveness of treatment
-
Detecting recurrence after therapy
Test Details
-
Sample Type: Blood (Serum)
-
Method: Immunoassay
-
Fasting Required: Not required
-
Reporting Time: 24–48 hours
Who Should Consider This Test
-
Patients diagnosed with CEA-producing cancers
-
Individuals undergoing cancer treatment
-
Post-surgical cancer monitoring
-
Doctor-recommended follow-up cases
Understanding the Results
-
Normal Range: Typically < 3 ng/mL (non-smokers)
-
Slightly higher levels may be seen in smokers
-
Elevated levels do not confirm cancer but require further evaluation
Key Benefits
✔ Helps track cancer treatment progress
✔ Supports early detection of recurrence
✔ Non-invasive and quick blood test
✔ Reliable tumor marker for multiple cancers
Precautions
CEA Test, Tumor Marker Test, Cancer Monitoring Blood Test, CEA Serum Test, Diagnostic Lab Test, Oncology Blood Test
#CEATest #CancerMarker #TumorMarker #HealthCheck #DiagnosticLab #CancerAwareness
